Kevin F. McLaughlin, SVP, CFO and Treasurer at ACCELERON PHARMA INC (XLRN), sold 5,315 shares at $42.37 ($227K) on 2019-01-02, disclosed to the SEC on 2019-01-04.
Open-market sale of $227k XLRN by SVP, CFO and Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.37 | 1,412 | $60K | 26.3% |
| 2 | $42.56 | 2,186 | $93K | 40.9% |
| 3 | $43.33 | 1,717 | $74K | 32.7% |
| Total | $42.76 avg | 5,315 | $227K | 100% |
| Filing → |
| VCEL | SELL | 2026-02-13 | $243K | — | Filing → |
| IVVD | BUY | 2025-11-20 | $125K | — | Filing → |
| VCEL | SELL | 2025-11-12 | $270K | — | Filing → |